Physician profile
Danielle Rice
NPI 1427587401
$832.67
in general payments reported to CMS, 2019-2025
12 companies · $489 in 2025
The $489 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13.86 · 2022: $27.54 · 2023: $33.16 · 2024: $269 · 2025: $489.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $791.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $791.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $226.88 | 2024-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $182.43 | 2023-2025 | |
| Novo Nordisk INC | $94.81 | 2024-2025 | |
| Hologic Sales and Service, LLC | $87.12 | 2024-2025 | Aptima, Thinprep 2000 Processor, Myosure Tissue Removal Device |
| Exeltis, USA INC. | $50.88 | 2025 | Slynd |
| Abbvie INC. | $42.52 | 2024-2025 | |
| Biogen, INC. | $37.40 | 2024-2025 | Zurzuvae |
| Exact Sciences Corporation | $32.85 | 2025 | Cologuard Collection Kit |
| Myriad Genetic Laboratories, INC. | $27.54 | 2022 | |
| Baxter Healthcare | $20.95 | 2025 | Perclot |
| Millicent US INC | $15.43 | 2025 | Intrarosa, Femlyv |
| Abbott Laboratories | $13.86 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danielle Rice listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.